Fluvastatin Sodium
Product Images NDC 68151-1334

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin Sodium (NDC 68151-1334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1334)

This is a prescription medication manufactured by Mylan in a 40 MG capsule form. The batch number is 052003 and the medication expires on August 2014. The code W0211149m7 is present, but its meaning is not clear.*

FDA Label Image

Fluvastatin Structural Formula (7f4945a8 B0a0 41ec 984c E2a34812bb8b 01)

FDA Label Image

Figure 1: Primary Endpoint (Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population))

FDA Label Image

Figure 2: Fluvastatin Capsules Intervention Prevention Study (Primary and Secondary Endpoints)

FDA Label Image

Figure 3: Change In Minimum Lumen Diameter (mm) (7f4945a8 B0a0 41ec 984c E2a34812bb8b 04)

FDA Label Image

Figure 4: Change In % Diameter Stenosis (7f4945a8 B0a0 41ec 984c E2a34812bb8b 05)

This seems to be a chart or a graph showing the percentage change in diameter stenosis for different types of therapies or medications. There are also some p-values along with the percentages. The text seems to be related to a medical study or research.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.